Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sweet bounce today. Cha-Ching!
EDXC
T0AD
Ready for the next big move here. I've been under the radar for a couple months but I've been adding where I can. Everything in the sector that I watch or play is taking a big dump. I look at this more as a sorting out the good from the bad scenario and EDXC is still holding its own.
Adding at these levels is a no brainer to anyone who has been around long enough to know.
As far as the arguing about who has better technology...come on...let's not be silly here. This is capitalism. The market needs EDXC in the way that consumers need a brand they can trust. The market also need companies like ER33 in the way that Walmart customers need a clearance item.
Know what you hold and just relax. Things will be back on track soon enough.
T0AD
I'd bet anything our new edibles will be placed in our new machine (as well as Autospense) and tracked by our own m3hub software...pretty ingenious if you ask me!
EDXC
T0AD
My guess is that many have realized that ERBB has turned itself into a PR machine...releasing more than 1 PR/week on average over the past month and a half. This draws a lot of attention in regards to the SEC and if they can't back up these claims and the SEC finds these PRs and new alliances with US Energy suspicious, it'll be PH*T all over again.
This PR, at best, was an effort to pump US Energy...notice the overuse of "bold" fonts. You don't see bolded items very often in a PR.
L2 looking good today! Currently 5000 @ .18 and a gap up to .24! Still early but I'm feeling good.
EDXC
T0AD
Congrats to you and others for holding from sub pennies. I bought in at .04 and have added ever since. Looking forward to big things here. I talked to Todd for a while last week about the Cannabis Cup and the two day business to business event and things are really coming together. I'm making a real estate investment tomorrow, will find out if I won the bid, but will be adding more here once I figure out what's left over. A year from now we'll all wish we were able to buy more in this range. GLTA!
EDXC
T0AD
No doubt! I remember sitting through the days from .12s down to .4s and the only thing that helped me get through was support from all the longs on this board including you. I added where I could and knew where we'd be when the time was right. I can't thank you, Ty, Nvidia, Blackbelt, TStarr and others enough for keeping the faith and staying strong. EDXC is absolutely my pride and joy & still a diamond in the rough. I've spoken with Todd on numerous occasions and have the same respect for you as I do for him.
The main thing that will continue to set us apart in the MJ sector is the leadership. I've been long here for a year and couldn't be happier with the performance. The sector wide scares will hold some of the tickers down but when people start to realize which side of the fence we're on (hint: state and federal regulatory compliance) we will pull away from the toxic effects of those trying to simply cash in on the hype that is MJ.
Plenty of awesome things in the works currently and more to come from what I've been hearing...truly exciting times.
Thank you and all the longs here for your help, insights, and patience as we continue to become a leader in the MJ sector. Once the market cools off from its overreaction to the recent halts, we'll be right back on track to dollars and a successful up listing per previous PR.
EDXC
T0AD
You're the man! Thanks for sharing!
EDXC
T0AD
BADA$$!!! Can you share a link! TIA!
T0AD
I'd panic too with VFIN on the ask...king of dilution. Look it up if your unfamiliar with that particular MM.
More like a dumpeth approacheth. Hope you guys loaded up on toilet paper this week...but I guess shares of ERBB could function as an equivalent.
Yes, I sold 5 shares of ERBB to cover the cost of playing another round after the game over.
ERBB 101: The PPS will open above the previous close...then drop about 5% for the majority of the day...followed by a close in the ballpark of down 7-10%.
Just watch, it happens ever time a PR releases which is 1-2 times per week lately.
Until that order goes though and until the Zazzz (which is still under construction per last PR) is placed... it's all fantasy.
The order is valued at $1.7 million...but by whom?
Where would ERBB even get the kind of cash to back an order worth $1.7 million?
These are the kinds of questions you should be asking as a shareholder as opposed to being satisfied with the potential order fluff being presented here. I've seen this all over the sector but when you check the quarterly...nothing ever goes through. They should have waited until the product was sold to release this news...soon to be a hard lesson learned.
It might be because ERBB has turned itself into a PR machine...11 PRs in less than two months. That's more than 1 PR/week on average.
I think we've all seen what happens to MJ tickers that draw this kind of attention through press releases.
I'll keep this on my SEC halt watchlist along with H*MP.
If I was ERBB I would have waited until the order shipped to put out a PR stating an order that is "valued" at $1.7mil.
I've made nothing but money off the MJ sector and never touched PH0T. Buying my first lake house on Thursday! With your luck, I'll drown in it...with my luck, I'll flip it in 2 years free of income tax. In the meantime, good luck to you...unfortunately you're going to need it as ERBB works relentlessly putting out PRs to try and save the PPS from falling to fair valuation in the .01-.03 range.
If I had any PH0T shares I'd take you up on that. In the meantime, I wouldn't take that bet with my ED><C shares because 10 of yours to 1000 of mine would be mean I'd have to put up $201 to your $0.505...you should brush up on your math skills...it might help with your trading!
I never invested in PH0T. It's just funny to me how ERBB is finally understanding what needs to go into a MJ vending machine before market. They put the cart before the horse on this one and are about to upset all the longs on this board when that machine never gets placed. Mark it
I wish! I'm just stating the ob-v
Top notch security? The Zazzz has a glass window displaying the product! This will never be placed in a dispensary due to the fact that anyone can break into it. That was a good one though.
Hilarious news! ED><C has been doing cloud for ages now. Welcome to the party! Late as usual...ERBB always about a year behind. This just cost shareholders even more as ERBB has ALMOST no revenues and will be forced to further dilute to make this deal happen. Next year you guys might even get into seed to sale tracking! What a joke
Shouldn't you guys be trading higher than EDXC by that logic? Strange how you can't get near us in terms of PPS. Your best bet, if you ever expect to trade in the range we do, is to BEG for a R/S...lmao!
Weren't you guys flirting with .10 a couple weeks ago and sitting in the .05s today?
EDXC
T0AD
Dixie showed their product at last years Cannabis Cup in the Autospense by ED><C. Just sayin
http://instagram.com/p/Yiqib8KnGs/
I wonder how many shares ERBB paid Dixie for this one! The BBQ cost them 2,000,000 so I can only imagine. I feel bad for shareholders as every move ERBB has made recently has been dilutive.
Name one company that doesn't have competition, lol! I wonder how many shares ERB* paid Dixie for this one! The BBQ cost them 2,000,000 so I can only imagine. I feel bad for their shareholders as every move ERB* has made recently has been dilutive.
EDXC
I've come to find that ERB* paid the owner of that restaurant 2 million shares to demo the unit there.
I can't wait to your coverage of the Cannabis Cup! Don't be conservative on the pics & videos!
EDXC
T0AD
By Popular Demand: Growth Capital Expo Day Two to Feature Expert Panel and Presentations by Top Marijuana-Related Companies
By Popular Demand: Growth Capital Expo Day Two to Feature Expert Panel and Presentations by Top Marijuana-Related Companies
LAS VEGAS, NV--(Marketwired - Apr 14, 2014) - An expanded discussion of the prospects and trends in investment in legal marijuana-related businesses, plus presentations by publicly traded and pre-IPO cannabis-related companies, will be featured on the second day program on May 1 at The Growth Capital Expo 2014, at the Caesars Palace conference center in Las Vegas, NV.
Day Two of the Expo will feature an expert panel of marijuana investors, medical practitioners and entrepreneurs to address the near and mid-term prospects for legal marijuana-related business models and sectors -- including current and emerging opportunities in pharmaceuticals, botanicals, business services and consumer goods. The panel will be moderated by Troy Dayton, founder of The ArcView Group, the first angel group dedicated to legal marijuana-related investment.
Joining Mr. Dayton is:
Justin Hartfield, The Ghost Group. Co-founder of WeedMaps.com, the first publicly traded marijuana-related company to surpass $15 million in annual sales, now an investor in marijuana-related startups. Board member of the National Cannabis Industry Association, the Marijuana Policy Project, and the National Organization for the Reform of Marijuana Laws.
Dr. Lawrence May, Tauriga Sciences. Member of Medical Advisory Board at Tauriga Sciences (OTCQB: TAUG), a publicly traded life science holding company that is focused on proprietary biotherapeutics and diagnostics using cannabis-derived compounds. Former executive vice president for medical and scientific affairs for Herbalife International; on the clinical faculty of the UCLA medical school.
Doug Leighton, Dutchess Capital. Co-founder and principal of Dutchess Capital, a micro-cap focused hedge fund with more than $2 billion in transactional value over a decade of investing. Now a member of the investment committee at ArcView Group, and an active investor and board member for several marijuana-related companies.
Dr. Mark L. Rabe, Medical Marijuana Sciences. Dr. Rabe is Chairman of the Scientific Advisory Board of Medical Marijuana Sciences, a subsidiary of Nuvilex, Inc. (OTCQB: NVLX), an international biotechnology company providing cell and gene therapy solutions for the treatment of diseases. Dr. Rabe is the former Chief Medical Officer of the largest group of physician-owned alternative medicine clinics in California.
Khurshid Khoja, Greenbridge Corporate Counsel. In addition to leading the Cannabis & Hemp Industry practice at Greenbridge, Khurshid currently serves on the Board of Directors of the California Cannabis Industry Association and the Illinois Cannabis Industry Association. Prior to founding Greenbridge, Khurshid practiced corporate and transactional law at Thelen LLP and Reed Smith LLP.
The 60-minute panel, titled "By Popular Demand: Opportunities For Institutional Investment In Marijuana-Related Companies," will highlight a of full day of marijuana investment programming, including investor presentations by the chief executives of six publicly traded companies pursuing medical marijuana and cannabis-related strategies, including Nuvilex (OTCQB: NVLX), Tauriga Sciences, MedBox (OTCQB: MDBX), Advanced Cannabis Solutions, Endexx (PINKSHEETS: EDXC) and BreedIT (OTCQB: BRDT).
More information on the presenting companies is available on the Expo website, http://growthcapitalexpo.com/presenting-companies/.
"Day Two of this year's Growth Capital Expo is devoted entirely to the innovations in the capital markets resulting from the democratization of capital investment embodied in the JOBS Act," said Brett Goetschius, Editor and Publisher of Growth Capital Investor, and co-host of the Expo. "It's where Wall Street meets Crowd Street. And I can think of no better example where the sentiment of the crowd is driving markets harder and faster than in the area of marijuana-related goods and services. The people are speaking, with their actions, their votes and their dollars. Investors ignore them at their peril."
To make the "By Popular Demand" panel available to the widest possible audience, special reduced-price Day Two-only tickets are available online at the Expo website. The single-day ticket offers complete access to the full day of Expo programs and presentations on crowdsourced capital and investment, including the full schedule of presentations by over 50 public and private emerging growth companies. To purchase the special Day Two ticket, go to http://growthcapitalexpo.com/register.
Forward-Looking Statements
This news release may include certain forward-looking statements. All statements, other than statements of historical fact, included in this release are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. This notice expressly qualifies all forward-looking statements in this release. The Company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessary estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors, factors that could cause actual results to differ materially from those estimated by the Company. They include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors, which may be identified, from time to time in the Company's public announcements.
Contact:
Robert Kraft
Email Contact
Sweet! I had no idea there was a B2B trades how before the cannabis cup. This is excellent news! Leave it to Endexx to find a way to fit 100 unique products in a machine that size! $$$
EDXC
T0AD
Sounds great! Keep us posted!
EDXC
T0AD
I think you might be wrong about that. It looks like they do retail and wholesale like the PR says. I found this on their Facebook page. DD pays once again!
http://mymaplist.com/maps/v/HWNsi1cS
EDXC
T0AD
In the event of a merger, the ticker would change and your shares would become Bio shares. This is all in my opinion but what I'm hoping for.
T0AD
No, hemp holders receive BioAdaptives stock which BioAdaptives holds CLNP shares so kind of the other way around.
T0AD
I'm screaming! Haha! Great find!!!
T0AD
I was digging up some info on them too. Looks like they were voted Top 10 in America. Things are about to get crazy here!
http://www.dessertprofessional.com/index.php/top-ten-chefs/135-2013-honors/360-dessert-professionals-top-ten-frozen-dessert-retailers-in-america-2013
EDXC
T0AD
PR from EDXC just released!
Endexx to Develop Consumable CBD Products
Endexx to Develop Consumable CBD Products
Endexx Engages Todd Zarlengo to Act as Co-Developer of CBD and Medical Marijuana Consumable Division
CAVE CREEK, AZ--(Marketwired - Apr 9, 2014) - Endexx Corporation (OTC Pink: EDXC) (PINKSHEETS: EDXC), a provider of innovative medical marijuana management and technology solutions, announces a collaboration agreement with Todd Zarlengo, a leading Italian dessert chef and entrepreneur, to develop the manufacturing, packaging and labeling protocols for the successful launch of Endexx's new medical marijuana consumable division. The new division will focus on edible delivery systems for medical applications of cannabidiol extracts in the form of CBD-infused "cannsumer" goods for the rapidly growing $1.5 billion U.S. medical marijuana market.
Todd Zarlengo stated: "Like my father Tom, I have dedicated my life to the art of hand-made, artisanal ice cream, Italian ice, gelato and sorbet. Our family has been in the business of wholesaling and retailing frozen desserts for 31 years and I am overjoyed to bring my expertise in manufacturing premium quality frozen desserts to Endexx. We are excited to introduce the first product line of our all-new 'Cannsumer Goods' division. The debut of our new and exciting line of 'Cannsumable' products will feature all natural, CBD-infused liquid and frozen desserts. The line combines the medicinal properties of CBD in an assortment of fruit flavors that are absolutely delicious."
Todd Davis, Chairman and CEO of Endexx, said, "Mr. Zarlengo brings expertise and passion to our new Cannsumable product line. He will collaborate in all aspects of the success of this new division and unique product line. His experience in freezable and frozen products immediately positions Endexx for market leadership in CBD-infused edible products for use by patients and consumers seeking alternative therapeutic support. In addition, Mr. Zarlengo's experience in wholesaling and retailing will be crucial in building a profitable enterprise from its inception."
Cannabidiol (CBD) is a non-psychoactive natural compound that has been shown in scientific and clinical studies to possess beneficial properties in the treatment of a wide range of conditions, including arthritis, diabetes, MS, PTSD, skin cancer, epilepsy and other disorders. As mounting scientific evidence proves the efficacy of CBD in treating a wide variety of debilitating conditions, traditionally conservative states that have not supported legalization of medical marijuana are introducing legislation to legalize the use of CBD in treating medical conditions. In the last 30 days, Alabama, Georgia, Tennessee, Kentucky, Indiana, Wisconsin, Utah and Florida all have introduced or passed bills to legalize the use of CBD in the treatment of epilepsy and other debilitating conditions. Recent media coverage around the use a strain of cannabis called "Charlotte's Web," popular for its high CBD count and used to treat seizure-related disorders, has raised the profile of CBD's benefits.
About Endexx :
www.endexx.com www.gsgsolar.com www.m3hub.com www.autospense.com
Endexx Corporation collaborates with independent software engineers and architects, scientists, engineers, and other innovators to build businesses that can thrive collectively in the equity markets. The Endexx team recognizes that individually, development stage technology companies face extreme difficulty surviving as independent organizations. Through its collaborative practices, individual and group skill sets are synergistically applied to develop unique technologies and grow the businesses, while centralizing costs and eliminating redundancies. Endexx provides a platform for entrepreneurs to thrive, offering maximum return on investment through equity ownership in the parent corporation. Each entrepreneur is an Endexx shareholder, incentivized to contribute to the overall objective of increasing shareholder value. Endexx's management team and its advisory group each have a minimum of 10-50 years of experience in their field of expertise. The parent company's management has extensive experience growing businesses, developing and implementing new technologies and running publicly traded corporations.
Contact Endexx via email to receive corporate news and updates at Endexx@endexx.com.
http://www.otcmarkets.com/stock/EDXC/quote
Safe Harbor Notice: This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.
Endexx Corporation
Todd Davis
Chairman & CEO
endexx@endexx.com
M3Hub Sales: 480-999-0097
Investor Relations
IRTH Communications
Andrew Haag
Managing Partner
EDXC@irthcommunications.com
866-976-4784
Awesome PR out out by EDXC just now!
Endexx to Develop Consumable CBD Products
Endexx to Develop Consumable CBD Products
Endexx Engages Todd Zarlengo to Act as Co-Developer of CBD and Medical Marijuana Consumable Division
CAVE CREEK, AZ--(Marketwired - Apr 9, 2014) - Endexx Corporation (OTC Pink: EDXC) (PINKSHEETS: EDXC), a provider of innovative medical marijuana management and technology solutions, announces a collaboration agreement with Todd Zarlengo, a leading Italian dessert chef and entrepreneur, to develop the manufacturing, packaging and labeling protocols for the successful launch of Endexx's new medical marijuana consumable division. The new division will focus on edible delivery systems for medical applications of cannabidiol extracts in the form of CBD-infused "cannsumer" goods for the rapidly growing $1.5 billion U.S. medical marijuana market.
Todd Zarlengo stated: "Like my father Tom, I have dedicated my life to the art of hand-made, artisanal ice cream, Italian ice, gelato and sorbet. Our family has been in the business of wholesaling and retailing frozen desserts for 31 years and I am overjoyed to bring my expertise in manufacturing premium quality frozen desserts to Endexx. We are excited to introduce the first product line of our all-new 'Cannsumer Goods' division. The debut of our new and exciting line of 'Cannsumable' products will feature all natural, CBD-infused liquid and frozen desserts. The line combines the medicinal properties of CBD in an assortment of fruit flavors that are absolutely delicious."
Todd Davis, Chairman and CEO of Endexx, said, "Mr. Zarlengo brings expertise and passion to our new Cannsumable product line. He will collaborate in all aspects of the success of this new division and unique product line. His experience in freezable and frozen products immediately positions Endexx for market leadership in CBD-infused edible products for use by patients and consumers seeking alternative therapeutic support. In addition, Mr. Zarlengo's experience in wholesaling and retailing will be crucial in building a profitable enterprise from its inception."
Cannabidiol (CBD) is a non-psychoactive natural compound that has been shown in scientific and clinical studies to possess beneficial properties in the treatment of a wide range of conditions, including arthritis, diabetes, MS, PTSD, skin cancer, epilepsy and other disorders. As mounting scientific evidence proves the efficacy of CBD in treating a wide variety of debilitating conditions, traditionally conservative states that have not supported legalization of medical marijuana are introducing legislation to legalize the use of CBD in treating medical conditions. In the last 30 days, Alabama, Georgia, Tennessee, Kentucky, Indiana, Wisconsin, Utah and Florida all have introduced or passed bills to legalize the use of CBD in the treatment of epilepsy and other debilitating conditions. Recent media coverage around the use a strain of cannabis called "Charlotte's Web," popular for its high CBD count and used to treat seizure-related disorders, has raised the profile of CBD's benefits.
About Endexx :
www.endexx.com www.gsgsolar.com www.m3hub.com www.autospense.com
Endexx Corporation collaborates with independent software engineers and architects, scientists, engineers, and other innovators to build businesses that can thrive collectively in the equity markets. The Endexx team recognizes that individually, development stage technology companies face extreme difficulty surviving as independent organizations. Through its collaborative practices, individual and group skill sets are synergistically applied to develop unique technologies and grow the businesses, while centralizing costs and eliminating redundancies. Endexx provides a platform for entrepreneurs to thrive, offering maximum return on investment through equity ownership in the parent corporation. Each entrepreneur is an Endexx shareholder, incentivized to contribute to the overall objective of increasing shareholder value. Endexx's management team and its advisory group each have a minimum of 10-50 years of experience in their field of expertise. The parent company's management has extensive experience growing businesses, developing and implementing new technologies and running publicly traded corporations.
Contact Endexx via email to receive corporate news and updates at Endexx@endexx.com.
http://www.otcmarkets.com/stock/EDXC/quote
Safe Harbor Notice: This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.
Endexx Corporation
Todd Davis
Chairman & CEO
endexx@endexx.com
M3Hub Sales: 480-999-0097
Investor Relations
IRTH Communications
Andrew Haag
Managing Partner
EDXC@irthcommunications.com
866-976-4784
EDXC PR just released!
Endexx to Develop Consumable CBD Products
Endexx to Develop Consumable CBD Products
Endexx Engages Todd Zarlengo to Act as Co-Developer of CBD and Medical Marijuana Consumable Division
CAVE CREEK, AZ--(Marketwired - Apr 9, 2014) - Endexx Corporation (OTC Pink: EDXC) (PINKSHEETS: EDXC), a provider of innovative medical marijuana management and technology solutions, announces a collaboration agreement with Todd Zarlengo, a leading Italian dessert chef and entrepreneur, to develop the manufacturing, packaging and labeling protocols for the successful launch of Endexx's new medical marijuana consumable division. The new division will focus on edible delivery systems for medical applications of cannabidiol extracts in the form of CBD-infused "cannsumer" goods for the rapidly growing $1.5 billion U.S. medical marijuana market.
Todd Zarlengo stated: "Like my father Tom, I have dedicated my life to the art of hand-made, artisanal ice cream, Italian ice, gelato and sorbet. Our family has been in the business of wholesaling and retailing frozen desserts for 31 years and I am overjoyed to bring my expertise in manufacturing premium quality frozen desserts to Endexx. We are excited to introduce the first product line of our all-new 'Cannsumer Goods' division. The debut of our new and exciting line of 'Cannsumable' products will feature all natural, CBD-infused liquid and frozen desserts. The line combines the medicinal properties of CBD in an assortment of fruit flavors that are absolutely delicious."
Todd Davis, Chairman and CEO of Endexx, said, "Mr. Zarlengo brings expertise and passion to our new Cannsumable product line. He will collaborate in all aspects of the success of this new division and unique product line. His experience in freezable and frozen products immediately positions Endexx for market leadership in CBD-infused edible products for use by patients and consumers seeking alternative therapeutic support. In addition, Mr. Zarlengo's experience in wholesaling and retailing will be crucial in building a profitable enterprise from its inception."
Cannabidiol (CBD) is a non-psychoactive natural compound that has been shown in scientific and clinical studies to possess beneficial properties in the treatment of a wide range of conditions, including arthritis, diabetes, MS, PTSD, skin cancer, epilepsy and other disorders. As mounting scientific evidence proves the efficacy of CBD in treating a wide variety of debilitating conditions, traditionally conservative states that have not supported legalization of medical marijuana are introducing legislation to legalize the use of CBD in treating medical conditions. In the last 30 days, Alabama, Georgia, Tennessee, Kentucky, Indiana, Wisconsin, Utah and Florida all have introduced or passed bills to legalize the use of CBD in the treatment of epilepsy and other debilitating conditions. Recent media coverage around the use a strain of cannabis called "Charlotte's Web," popular for its high CBD count and used to treat seizure-related disorders, has raised the profile of CBD's benefits.
About Endexx :
www.endexx.com www.gsgsolar.com www.m3hub.com www.autospense.com
Endexx Corporation collaborates with independent software engineers and architects, scientists, engineers, and other innovators to build businesses that can thrive collectively in the equity markets. The Endexx team recognizes that individually, development stage technology companies face extreme difficulty surviving as independent organizations. Through its collaborative practices, individual and group skill sets are synergistically applied to develop unique technologies and grow the businesses, while centralizing costs and eliminating redundancies. Endexx provides a platform for entrepreneurs to thrive, offering maximum return on investment through equity ownership in the parent corporation. Each entrepreneur is an Endexx shareholder, incentivized to contribute to the overall objective of increasing shareholder value. Endexx's management team and its advisory group each have a minimum of 10-50 years of experience in their field of expertise. The parent company's management has extensive experience growing businesses, developing and implementing new technologies and running publicly traded corporations.
Contact Endexx via email to receive corporate news and updates at Endexx@endexx.com.
http://www.otcmarkets.com/stock/EDXC/quote
Safe Harbor Notice: This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.
Endexx Corporation
Todd Davis
Chairman & CEO
endexx@endexx.com
M3Hub Sales: 480-999-0097
Investor Relations
IRTH Communications
Andrew Haag
Managing Partner
EDXC@irthcommunications.com
866-976-4784
EDXC news out minutes ago!
Endexx to Develop Consumable CBD Products
Endexx to Develop Consumable CBD Products
Endexx Engages Todd Zarlengo to Act as Co-Developer of CBD and Medical Marijuana Consumable Division
CAVE CREEK, AZ--(Marketwired - Apr 9, 2014) - Endexx Corporation (OTC Pink: EDXC) (PINKSHEETS: EDXC), a provider of innovative medical marijuana management and technology solutions, announces a collaboration agreement with Todd Zarlengo, a leading Italian dessert chef and entrepreneur, to develop the manufacturing, packaging and labeling protocols for the successful launch of Endexx's new medical marijuana consumable division. The new division will focus on edible delivery systems for medical applications of cannabidiol extracts in the form of CBD-infused "cannsumer" goods for the rapidly growing $1.5 billion U.S. medical marijuana market.
Todd Zarlengo stated: "Like my father Tom, I have dedicated my life to the art of hand-made, artisanal ice cream, Italian ice, gelato and sorbet. Our family has been in the business of wholesaling and retailing frozen desserts for 31 years and I am overjoyed to bring my expertise in manufacturing premium quality frozen desserts to Endexx. We are excited to introduce the first product line of our all-new 'Cannsumer Goods' division. The debut of our new and exciting line of 'Cannsumable' products will feature all natural, CBD-infused liquid and frozen desserts. The line combines the medicinal properties of CBD in an assortment of fruit flavors that are absolutely delicious."
Todd Davis, Chairman and CEO of Endexx, said, "Mr. Zarlengo brings expertise and passion to our new Cannsumable product line. He will collaborate in all aspects of the success of this new division and unique product line. His experience in freezable and frozen products immediately positions Endexx for market leadership in CBD-infused edible products for use by patients and consumers seeking alternative therapeutic support. In addition, Mr. Zarlengo's experience in wholesaling and retailing will be crucial in building a profitable enterprise from its inception."
Cannabidiol (CBD) is a non-psychoactive natural compound that has been shown in scientific and clinical studies to possess beneficial properties in the treatment of a wide range of conditions, including arthritis, diabetes, MS, PTSD, skin cancer, epilepsy and other disorders. As mounting scientific evidence proves the efficacy of CBD in treating a wide variety of debilitating conditions, traditionally conservative states that have not supported legalization of medical marijuana are introducing legislation to legalize the use of CBD in treating medical conditions. In the last 30 days, Alabama, Georgia, Tennessee, Kentucky, Indiana, Wisconsin, Utah and Florida all have introduced or passed bills to legalize the use of CBD in the treatment of epilepsy and other debilitating conditions. Recent media coverage around the use a strain of cannabis called "Charlotte's Web," popular for its high CBD count and used to treat seizure-related disorders, has raised the profile of CBD's benefits.
About Endexx :
www.endexx.com www.gsgsolar.com www.m3hub.com www.autospense.com
Endexx Corporation collaborates with independent software engineers and architects, scientists, engineers, and other innovators to build businesses that can thrive collectively in the equity markets. The Endexx team recognizes that individually, development stage technology companies face extreme difficulty surviving as independent organizations. Through its collaborative practices, individual and group skill sets are synergistically applied to develop unique technologies and grow the businesses, while centralizing costs and eliminating redundancies. Endexx provides a platform for entrepreneurs to thrive, offering maximum return on investment through equity ownership in the parent corporation. Each entrepreneur is an Endexx shareholder, incentivized to contribute to the overall objective of increasing shareholder value. Endexx's management team and its advisory group each have a minimum of 10-50 years of experience in their field of expertise. The parent company's management has extensive experience growing businesses, developing and implementing new technologies and running publicly traded corporations.
Contact Endexx via email to receive corporate news and updates at Endexx@endexx.com.
http://www.otcmarkets.com/stock/EDXC/quote
Safe Harbor Notice: This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.
Endexx Corporation
Todd Davis
Chairman & CEO
endexx@endexx.com
M3Hub Sales: 480-999-0097
Investor Relations
IRTH Communications
Andrew Haag
Managing Partner
EDXC@irthcommunications.com
866-976-4784
Huge EDXC news just released Flex!
Endexx to Develop Consumable CBD Products
Endexx to Develop Consumable CBD Products
Endexx Engages Todd Zarlengo to Act as Co-Developer of CBD and Medical Marijuana Consumable Division
CAVE CREEK, AZ--(Marketwired - Apr 9, 2014) - Endexx Corporation (OTC Pink: EDXC) (PINKSHEETS: EDXC), a provider of innovative medical marijuana management and technology solutions, announces a collaboration agreement with Todd Zarlengo, a leading Italian dessert chef and entrepreneur, to develop the manufacturing, packaging and labeling protocols for the successful launch of Endexx's new medical marijuana consumable division. The new division will focus on edible delivery systems for medical applications of cannabidiol extracts in the form of CBD-infused "cannsumer" goods for the rapidly growing $1.5 billion U.S. medical marijuana market.
Todd Zarlengo stated: "Like my father Tom, I have dedicated my life to the art of hand-made, artisanal ice cream, Italian ice, gelato and sorbet. Our family has been in the business of wholesaling and retailing frozen desserts for 31 years and I am overjoyed to bring my expertise in manufacturing premium quality frozen desserts to Endexx. We are excited to introduce the first product line of our all-new 'Cannsumer Goods' division. The debut of our new and exciting line of 'Cannsumable' products will feature all natural, CBD-infused liquid and frozen desserts. The line combines the medicinal properties of CBD in an assortment of fruit flavors that are absolutely delicious."
Todd Davis, Chairman and CEO of Endexx, said, "Mr. Zarlengo brings expertise and passion to our new Cannsumable product line. He will collaborate in all aspects of the success of this new division and unique product line. His experience in freezable and frozen products immediately positions Endexx for market leadership in CBD-infused edible products for use by patients and consumers seeking alternative therapeutic support. In addition, Mr. Zarlengo's experience in wholesaling and retailing will be crucial in building a profitable enterprise from its inception."
Cannabidiol (CBD) is a non-psychoactive natural compound that has been shown in scientific and clinical studies to possess beneficial properties in the treatment of a wide range of conditions, including arthritis, diabetes, MS, PTSD, skin cancer, epilepsy and other disorders. As mounting scientific evidence proves the efficacy of CBD in treating a wide variety of debilitating conditions, traditionally conservative states that have not supported legalization of medical marijuana are introducing legislation to legalize the use of CBD in treating medical conditions. In the last 30 days, Alabama, Georgia, Tennessee, Kentucky, Indiana, Wisconsin, Utah and Florida all have introduced or passed bills to legalize the use of CBD in the treatment of epilepsy and other debilitating conditions. Recent media coverage around the use a strain of cannabis called "Charlotte's Web," popular for its high CBD count and used to treat seizure-related disorders, has raised the profile of CBD's benefits.
About Endexx :
www.endexx.com www.gsgsolar.com www.m3hub.com www.autospense.com
Endexx Corporation collaborates with independent software engineers and architects, scientists, engineers, and other innovators to build businesses that can thrive collectively in the equity markets. The Endexx team recognizes that individually, development stage technology companies face extreme difficulty surviving as independent organizations. Through its collaborative practices, individual and group skill sets are synergistically applied to develop unique technologies and grow the businesses, while centralizing costs and eliminating redundancies. Endexx provides a platform for entrepreneurs to thrive, offering maximum return on investment through equity ownership in the parent corporation. Each entrepreneur is an Endexx shareholder, incentivized to contribute to the overall objective of increasing shareholder value. Endexx's management team and its advisory group each have a minimum of 10-50 years of experience in their field of expertise. The parent company's management has extensive experience growing businesses, developing and implementing new technologies and running publicly traded corporations.
Contact Endexx via email to receive corporate news and updates at Endexx@endexx.com.
http://www.otcmarkets.com/stock/EDXC/quote
Safe Harbor Notice: This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.
Endexx Corporation
Todd Davis
Chairman & CEO
endexx@endexx.com
M3Hub Sales: 480-999-0097
Investor Relations
IRTH Communications
Andrew Haag
Managing Partner
EDXC@irthcommunications.com
866-976-4784